Nothing Special   »   [go: up one dir, main page]

FR2183806A1 - - Google Patents

Info

Publication number
FR2183806A1
FR2183806A1 FR7316142A FR7316142A FR2183806A1 FR 2183806 A1 FR2183806 A1 FR 2183806A1 FR 7316142 A FR7316142 A FR 7316142A FR 7316142 A FR7316142 A FR 7316142A FR 2183806 A1 FR2183806 A1 FR 2183806A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7316142A
Other languages
French (fr)
Other versions
FR2183806B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni and C SpA
Original Assignee
Maggioni and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni and C SpA filed Critical Maggioni and C SpA
Publication of FR2183806A1 publication Critical patent/FR2183806A1/fr
Application granted granted Critical
Publication of FR2183806B1 publication Critical patent/FR2183806B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7316142A 1972-05-05 1973-05-04 Expired FR2183806B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2392572 1972-05-05

Publications (2)

Publication Number Publication Date
FR2183806A1 true FR2183806A1 (en) 1973-12-21
FR2183806B1 FR2183806B1 (en) 1976-05-14

Family

ID=11210914

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7316142A Expired FR2183806B1 (en) 1972-05-05 1973-05-04

Country Status (12)

Country Link
US (1) US3870720A (en)
JP (1) JPS49132221A (en)
AU (1) AU469087B2 (en)
BE (1) BE799087A (en)
CA (1) CA982578A (en)
DE (1) DE2322699C2 (en)
DK (1) DK131033B (en)
FR (1) FR2183806B1 (en)
GB (1) GB1413008A (en)
NL (1) NL7306164A (en)
SE (1) SE400768B (en)
ZA (1) ZA732937B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (en) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー N-((3-Benzyl) -2,2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular disease
BR112015026513A2 (en) 2013-04-17 2017-07-25 Pfizer n-piperidin-3-ylbenzamide derivatives to treat cardiovascular disease
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2952680A (en) * 1960-09-13 Derivatives of x-quevazolone
US987847A (en) * 1910-04-12 1911-03-28 Rubin W Weeks Harness.
US3440244A (en) * 1958-02-17 1969-04-22 Pfizer & Co C 3,6-disubstituted-7-sulfamyl-1,2,4-benzthiazide-1,1-dioxides
US3072656A (en) * 1960-01-22 1963-01-08 Ciba Geigy Corp 2-cycloaliphatic-6-sulfamyl-7-halo(or trihalomethyl)-1, 2, 3, 4-tetrahydro-4-quinazolones
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOL. 71 1969 61 357 J CITE II FARMACO, ED. SCI. 1969, 24 2 , 199-220 ITAL. DOCUMENT CITE DANS LE TEXTE DE LA DEMANDE EXAMINEE ) *

Also Published As

Publication number Publication date
NL7306164A (en) 1973-11-07
DE2322699A1 (en) 1974-01-10
US3870720A (en) 1975-03-11
ZA732937B (en) 1974-03-27
FR2183806B1 (en) 1976-05-14
BE799087A (en) 1973-08-31
JPS49132221A (en) 1974-12-18
CA982578A (en) 1976-01-27
AU469087B2 (en) 1976-02-05
GB1413008A (en) 1975-11-05
AU5516173A (en) 1974-11-07
DK131033B (en) 1975-05-20
DE2322699C2 (en) 1983-10-27
DK131033C (en) 1975-10-06
SE400768B (en) 1978-04-10

Similar Documents

Publication Publication Date Title
JPS5618665B2 (en)
FR2169321B1 (en)
DK131033C (en)
FR2175689B1 (en)
FR2202019A1 (en)
JPS4962155U (en)
JPS492111U (en)
JPS4893303U (en)
JPS4914746U (en)
JPS4921014U (en)
CH555929A (en)
CH561602A5 (en)
CH563835A5 (en)
CH562419A5 (en)
CH562334A5 (en)
CH567658A5 (en)
CH571452A5 (en)
NL7304404A (en)
NL7308301A (en)
CH572756A5 (en)
CH575140B5 (en)
CH561935A5 (en)
CH561893A5 (en)
CH561881A5 (en)
CH591080A5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse